<DOC>
	<DOCNO>NCT01053715</DOCNO>
	<brief_summary>The aim study describe Health Related Quality Life ( HRQoL ) adolescents adults Hemophilia A treat prophylactically on-demand Helixate NexGen . The study also assess kind determinant , include key transitional life event , might impact HRQoL patient population .</brief_summary>
	<brief_title>Quality Life Study Helixate NexGen</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Haemophilia A patient Severely ( &lt; 1 % ) moderately ( 15 % ) affect On treatment Helixate NexGen Ability read understand study material ( patient information data protection form , patientrelated questionnaire ) Signed data protection form ; patient &lt; 18 year age , legal guardian must also give write consent sign data protection form Presence inhibitor Abuse recreational drug alcohol interfere everydaylife opinion physician Advanced stage human immunodeficiency virus ( HIV ) infection ( CD4 cell count &lt; 200/cmm , multidrug resistance , presence AIDS relate sign symptom ) Symptomatic liver disease ( cirrhosis , ascites , esophageal varix ) Concomitant plan interferon therapy Malignancies treatment</criteria>
	<gender>Male</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Hemophilia</keyword>
	<keyword>Quality Life</keyword>
</DOC>